Reprint

Sympathetic Nerves and Cardiovascular Diseases

Edited by
March 2024
192 pages
  • ISBN978-3-7258-0543-3 (Hardback)
  • ISBN978-3-7258-0544-0 (PDF)

This book is a reprint of the Special Issue Sympathetic Nerves and Cardiovascular Diseases that was published in

Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary

This Special Issue aims to assemble the latest perspectives and research findings to illuminate the role of altered sympathetic nerve activity (SNA) in cardiovascular disease (CVD) pathogenesis. It comprises one editorial article, five review articles, and six original research articles, which collectively emphasize the significance of SNA in the pathogenesis of various CVDs, including hypertension, atherosclerosis, heart failure, peripheral artery disease, diabetic wound healing, and chronic pain-associated CVDs.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
sympathetic nerve activity; arterial blood pressure; peripheral artery disease; static exercise; muscle afferent nerve; heat treatment; arterial stiffness; sympathetic nerves; PVAT; exercise; heart failure; asprosin; paraventricular nucleus; reactive oxygen species; sympathetic activity; blood pressure; arrhythmia; autonomic nervous system; cardiac sympathetic activation; heart failure; inflammation; stellate ganglion; NHE3; glomerular filtration rate; bicuculline; paraventricular nucleus of the hypothalamus; sympathetic nerve activity; acute heart failure; experimental model; heart rate variability; pig; diabetes mellitus; wound healing; sympathetic system; norepinephrine; acetylcholine; NPY; VIP; NGF; keratinocytes; angiogenesis; sympathetic activity; renal denervation; resistant hypertension; immune response; T cells; lymphocytes; pro-inflammatory cytokines; inflammation; energy expenditure; brown adipose tissue; obesity; diet-induced thermogenesis; sex differences; arcuate nucleus; paraventricular nucleus; obesity-induced inflammation; selective leptin resistance; weight regain; moxonidine; atherosclerosis; inflammation; cell migration; sympathetic nerve activity; chronic pain; cardiovascular disease; n/a